Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
First National Corp/VA (FXNC)
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
$30.35-3.71%
Close 2026-11-05 · 1-day change
NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
2.57 → 2.76 EPS · FY ending Dec 31, 2027 · 2 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 2; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for FXNC yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Sustain and increase dividend to at least $0.17 per share quarterly | The company steadily raises dividends to $0.17 per share, showing strong capital return. | Intact | Dividend per share falls below $0.17 quarterly | Dividend per share: $0.17 per share FY2026-Q2; GAAP. Published target: >=0.17 USD per share quarterly. Target period is not explicitly aligned with this observation. Aug 13, 20260.17 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
FXNC is a smaller-cap financial business with an organic-growth thesis, meaning growth from its existing operations. The thesis is on watch: recent earnings announcements have been positive, but financial performance remains weak relative to its industry cohort.
Valuation is rated neutral, with FXNC at a premium to peers and expectations broadly aligned with the evidence. The expectations gap is modest, and pricing fragility is low, so the snapshot does not point to unusually stretched expectations.
Management has delivered loan growth through relationship banking, reporting growth for both the year and the third quarter. Near term, expense control is less clear: third-quarter expenses rose sequentially, while recent financial performance remains weak relative to peers; the stated miss risk is low.
The multi-year view depends on continued loan growth and whether branch changes and expense management improve profitability. Near term, a guidance cut or lower interest rates would be unfavorable, while continued earnings strength at sector bellwethers could support sector momentum.
FXNC has evidence of loan-growth execution, but the thesis remains on watch as recent performance lags its industry cohort and profitability progress is not yet clear. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in First National Corp/VA's published investment case. The stated target is >=0.54 USD per share. |
| Intact |
| EPS falls below $0.54 in 2026 |
Diluted EPS: $0.76 per share FY2026-Q3; GAAP. Published target: >=0.54 USD per share. Target period is not explicitly aligned with this observation. Oct 23, 20260.76 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Limit revenue decline to no worse than -1% in next 12 months | A supporting condition in First National Corp/VA's published investment case. The stated target is >= -1% YoY revenue growth. | Intact | Revenue decline exceeds -1% YoY | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$2.53 → $2.76 · observed estimates
$0.10B → $0.10B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $2.53 | $98,285,500 | 3 / 2 |
| 2026-07-25 | $2.53 | $98,285,500 | 3 / 2 |
| 2026-07-26 | $2.53 | $98,285,500 | 3 / 2 |
| 2026-07-27 | $2.53 | $98,285,600 | 2 / 2 |
| 2026-07-28 | $2.53 | $98,285,600 | 2 / 2 |
| 2026-07-29 | $2.53 | $98,285,500 | 3 / 2 |
| 2026-07-30 | $2.53 | $98,285,500 | 3 / 2 |
| 2026-07-31 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-01 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-02 | $2.57 | $99,657,500 | 2 / 1 |
| 2026-08-03 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-04 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-05 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-06 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-07 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-08 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-09 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-10 | $2.57 | $99,657,500 | 3 / 2 |
| 2026-08-12 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-13 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-14 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-15 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-16 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-17 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-18 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-19 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-20 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-21 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-22 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-23 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-24 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-25 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-26 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-27 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-28 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-29 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-30 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-08-31 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-01 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-02 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-03 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-04 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-05 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-06 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-07 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-08 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-09 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-10 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-11 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-12 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-13 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-14 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-15 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-16 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-17 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-18 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-19 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-20 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-21 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-22 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-23 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-24 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-25 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-26 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-27 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-28 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-29 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-09-30 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-01 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-02 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-03 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-04 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-05 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-06 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-07 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-08 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-09 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-10 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-11 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-12 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-13 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-14 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-15 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-16 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-17 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-18 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-19 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-20 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-21 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-22 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-23 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-24 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-25 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-26 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-27 | $2.57 | $99,657,500 | 2 / 2 |
| 2026-10-28 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-10-29 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-10-30 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-10-31 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-11-01 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-11-02 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-11-03 | $2.76 | $101,602,000 | 2 / 2 |
| 2026-11-04 | $2.76 | $101,602,000 | 2 / 2 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 0 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.